OOIR: Observatory of International Research

Papers

(The H4-Index of Current Oncology Reports is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Immunotherapeutic and Targeted Strategies for Managing Brain Metastases from Common Cancer Origins: A State-of-the-Art Review	156
The Value Proposition of Observation Medicine in Managing Acute Oncologic Pain	153
Changing the Perspective on Fertility Preservation for Women with Metastatic or Advanced Stage Cancer	110
New Developments in VHL-Associated Neuroendocrine Neoplasms	105
Management of Upper Tract Urothelial Carcinoma	77
Shifting Epidemiology of Hepatocellular Carcinoma in Far Eastern and Southeast Asian Patients: Explanations and Implications	69
Advances in Targeted Therapy for Neurofibromatosis Type 2 (NF2)-Associated Vestibular Schwannomas	60
Integrating Precision Medicine into the Contemporary Management of Gynecologic Cancers	56
Treatment of Metastatic Melanoma in the Elderly	46
Immunotherapy in Biliary Tract Cancers: Where Are We?	46
Cardiotoxic Effects Following CAR-T Cell Therapy: A Literature Review	45
Functional Outcomes and Quality of Life in Patients with Sinonasal, Nasopharyngeal, and Anterior Skull Base Tumors	40
Hairy Cell Leukemia (HCL) and HCL Variant: Updates and Spotlights on Therapeutic Advances	39
Fatty Acid Metabolism and Cancer Immunotherapy	39
Brain Prehabilitation for Oncologic Surgery	38
NRG1 Fusions: The New Kid on the Block	37
Surgical Management of Melanoma: Advances and Updates	37
Management of In-Transit Metastases	36
An Integrated Care Approach to Improve Well-Being in Breast Cancer Patients	34
The Underestimated and Overlooked Burden of Diarrhea and Constipation in Cancer Patients	34
Current Trends and Challenges of Microbiome Research in Prostate Cancer	34
Opportunities and Challenges for a Histology-Agnostic Utilization of Trastuzumab Deruxtecan	32
Head and Neck Mucosal Melanoma: Where Are We Now?	32
The Microbiome in Advanced Melanoma: Where Are We Now?	31
Cellular Therapy in NSCLC: Between Myth and Reality	31

“What Should I Eat?”—Addressing Questions and Challenges Related to Nutrition in the Integrative Oncology Setting	30
Anti-PD-1: When to Stop Treatment	30
Development of Delivery Systems for Local Administration of Cytokines/Cytokine Gene-Directed Therapeutics: Modern Oncologic Implications	29
The Provision of Complementary, Alternative, and Integrative Medicine Information and Services: a Review of World Leading Oncology Hospital Websites	29